B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation
Related Experiment Video
Updated: Jun 10, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Girish Jayadeva1, Alison Kurimchak, Judit Garriga
1Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Abstract:
Pocket proteins negatively regulate transcription of E2F-dependent genes and progression through the G(0)/G(1) transition and the cell cycle restriction point in G(1). Pocket protein repressor activities are inactivated via phosphorylation at multiple Pro-directed Ser/Thr sites by the coordinated action of G(1) and G(1)/S cyclin-dependent kinases. These phosphorylations are reversed by the action of two families of Ser/Thr phosphatases: PP1, which has been implicated in abrupt dephosphorylation of retinoblastoma protein (pRB) in mitosis, and PP2A, which plays a role in an equilibrium that counteracts cyclin-dependent kinase (CDK) action throughout the cell cycle. However, the identity of the trimeric PP2A holoenzyme(s) functioning in this process is unknown. Here we report the identification of a PP2A trimeric holoenzyme containing B55α, which plays a major role in restricting the phosphorylation state of p107 and inducing its activation in human cells. Our data also suggest targeted selectivity in the interaction of pocket proteins with distinct PP2A holoenzymes, which is likely necessary for simultaneous pocket protein activation.
Insights
Researchers identified a specific PP2A holoenzyme containing B55α that is crucial for activating pocket proteins like p107. This finding clarifies the cell cycle regulation mechanisms involving protein phosphatases and cyclin-dependent kinases.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Protein Phosphatase Function
Background:
- Pocket proteins (e.g., pRB, p107) are key negative regulators of cell cycle progression, controlling E2F-dependent gene transcription.
- Their repressor activity is modulated by phosphorylation mediated by G1 and G1/S cyclin-dependent kinases (CDKs).
- Serine/threonine phosphatases, specifically PP1 and PP2A, reverse these phosphorylations, although the specific PP2A holoenzymes involved remain unidentified.
Purpose of the Study:
- To identify the specific PP2A holoenzyme responsible for dephosphorylating and activating pocket proteins.
- To elucidate the role of distinct PP2A holoenzymes in regulating pocket protein function and cell cycle progression.
Main Methods:
- Identification of PP2A holoenzyme complexes interacting with pocket proteins in human cells.
- Analysis of the phosphorylation status of pocket proteins (p107) in relation to PP2A holoenzyme activity.
- Investigating the functional consequences of PP2A holoenzyme activity on pocket protein activation.
Main Results:
- A PP2A trimeric holoenzyme containing the B55α regulatory subunit was identified as playing a major role in p107 dephosphorylation and activation.
- The study suggests that different pocket proteins interact selectively with distinct PP2A holoenzymes.
- This selective interaction is proposed to be essential for the coordinated activation of multiple pocket proteins.
Conclusions:
- The B55α-containing PP2A holoenzyme is a critical component in the regulation of pocket protein p107 activity.
- Targeted selectivity in PP2A holoenzyme interactions with pocket proteins ensures proper cell cycle control.
- This research clarifies the phosphatase-mediated mechanisms governing cell cycle restriction points.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation

